Relationship between the door-to-TIMI-3 flow time and the infarct size in patients suffering from acute myocardial infarction: analysis based on the fibrinolysis and subsequent transluminal (FAST-3) trial.
Watanabe, Kazuhiro
Relationship between the door-to-TIMI-3 flow time and the infarct size in patients suffering from acute myocardial infarction: analysis based on the fibrinolysis and subsequent transluminal (FAST-3) trial. [electronic resource] - Circulation journal : official journal of the Japanese Circulation Society Apr 2004 - 280-5 p. digital
Publication Type: Journal Article
1346-9843
10.1253/circj.68.280 doi
Aged
Anticoagulants--therapeutic use
Aspirin--administration & dosage
Biomarkers
Coronary Circulation
Creatine Kinase--blood
Creatine Kinase, MB Form
Drug Therapy, Combination
Electrocardiography
Emergency Service, Hospital--statistics & numerical data
Female
Fibrinolysis
Fibrinolytic Agents--administration & dosage
Heparin--administration & dosage
Hospitals, University--statistics & numerical data
Humans
Isoenzymes--blood
Japan--epidemiology
Male
Middle Aged
Myocardial Infarction--blood
Myocardial Reperfusion--methods
Patient Admission--statistics & numerical data
Plasminogen Activators--administration & dosage
Prospective Studies
Recombinant Proteins--administration & dosage
Risk Factors
Stroke Volume
Thrombolytic Therapy--statistics & numerical data
Time Factors
Tissue Plasminogen Activator--administration & dosage
Treatment Outcome
Troponin T--blood
Urokinase-Type Plasminogen Activator--administration & dosage
Relationship between the door-to-TIMI-3 flow time and the infarct size in patients suffering from acute myocardial infarction: analysis based on the fibrinolysis and subsequent transluminal (FAST-3) trial. [electronic resource] - Circulation journal : official journal of the Japanese Circulation Society Apr 2004 - 280-5 p. digital
Publication Type: Journal Article
1346-9843
10.1253/circj.68.280 doi
Aged
Anticoagulants--therapeutic use
Aspirin--administration & dosage
Biomarkers
Coronary Circulation
Creatine Kinase--blood
Creatine Kinase, MB Form
Drug Therapy, Combination
Electrocardiography
Emergency Service, Hospital--statistics & numerical data
Female
Fibrinolysis
Fibrinolytic Agents--administration & dosage
Heparin--administration & dosage
Hospitals, University--statistics & numerical data
Humans
Isoenzymes--blood
Japan--epidemiology
Male
Middle Aged
Myocardial Infarction--blood
Myocardial Reperfusion--methods
Patient Admission--statistics & numerical data
Plasminogen Activators--administration & dosage
Prospective Studies
Recombinant Proteins--administration & dosage
Risk Factors
Stroke Volume
Thrombolytic Therapy--statistics & numerical data
Time Factors
Tissue Plasminogen Activator--administration & dosage
Treatment Outcome
Troponin T--blood
Urokinase-Type Plasminogen Activator--administration & dosage